Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05089877 · ClinicalTrials.gov registry record

FREEZE-AFIB Post-Market Study

A clinical trial of Atrial Fibrillation and Atrial Flutter, sponsored by AtriCure.

Completed
Registry status
39
Enrollment target
6
Study locations

NCT05089877: Completed study of Atrial Fibrillation and Atrial Flutter, sponsored by AtriCure.

NCT05089877 is a study of Atrial Fibrillation and Atrial Flutter that has completed, run by AtriCure. The registered enrollment target is 39 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05089877, a study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by AtriCure.

COMPLETED
Registry status
39 participants
Enrollment target
6
Study locations

Study Summary

This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.

Primary Outcome

Death, stroke (regardless of level of disability), myocardial infarction, and major bleeding events within 30-days of the index ablation procedure. Measured by number of patients with Treatment-Related Adverse Events.

Conditions Studied

Atrial Fibrillation Atrial Flutter

Interventions

  • DEVICE Surgical Ablation

Study Locations (6)

Connecticut

  • Hartford Hospital - Hartford
  • Yale University School of Medicine - New Haven

Illinois

  • Northwestern University - Evanston

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Tennessee

  • Saint Thomas West Hospital - Nashville

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2022-04-29
Est. Completion 2023-12-31
AtriCure

23 total trials

What the finished NCT05089877 record still lists

NCT05089877 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Surgical Ablation is the first listed.

NCT05089877 lists 6 locations in 5 states (Connecticut, Illinois, Michigan).

Frequently Asked Questions

What is clinical trial NCT05089877 about?

NCT05089877 is a clinical study titled "FREEZE-AFIB Post-Market Study". This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.

What is the current status of trial NCT05089877?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2022-04-29. Estimated completion is 2023-12-31.

What conditions does trial NCT05089877 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.

What interventions are being tested in trial NCT05089877?

The interventions under investigation include: Surgical Ablation (DEVICE).

Who is sponsoring clinical trial NCT05089877?

This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05089877 being conducted?

This trial has 6 study locations across Connecticut, Illinois, Michigan, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05089877's enrollment target sits among peer trials

39 183rd of 202 higher than 20 of 202 other Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05089877, the US trial registry maintained by the National Library of Medicine. NCT05089877 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.